Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult Subjects
Clinical trial NCT04446000 · TERMINATED
Trial details
- NCT number
- NCT04446000
- Sponsor
- CSL Behring
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-23
- Primary completion
- 2023-03-28
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.